Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of ADCC-optimized antibodies for treating weak patients

Use of ADCC-optimized antibodies for treating weak patients

US Patent 8501171 · Granted Aug 6, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric protein in the treatment of amyloidosis2025
Use of modified Fc fragments in immunotherapy2025
Fc mutants with modified functional activity2023
Markers of immune response2021
Sialylated fetuin-A as a marker of immunotherapy efficacy2021
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Cell line overexpressing human CD303 antigen2019
Methods for identifying dendritic cell subsets, for determining if a patient is 2019
Pharmaceutical compositions comprising an antibody which binds the human anti-Mü2019